IBDEI0MQ ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10214,2)
;;=^5002665
;;^UTILITY(U,$J,358.3,10215,0)
;;=E11.9^^39^431^35
;;^UTILITY(U,$J,358.3,10215,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10215,1,3,0)
;;=3^DM Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,10215,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,10215,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,10216,0)
;;=E11.29^^39^431^27
;;^UTILITY(U,$J,358.3,10216,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10216,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Kidney Compl
;;^UTILITY(U,$J,358.3,10216,1,4,0)
;;=4^E11.29
;;^UTILITY(U,$J,358.3,10216,2)
;;=^5002631
;;^UTILITY(U,$J,358.3,10217,0)
;;=E11.311^^39^431^14
;;^UTILITY(U,$J,358.3,10217,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10217,1,3,0)
;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
;;^UTILITY(U,$J,358.3,10217,1,4,0)
;;=4^E11.311
;;^UTILITY(U,$J,358.3,10217,2)
;;=E11.319^5002632
;;^UTILITY(U,$J,358.3,10218,0)
;;=E11.319^^39^431^15
;;^UTILITY(U,$J,358.3,10218,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10218,1,3,0)
;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
;;^UTILITY(U,$J,358.3,10218,1,4,0)
;;=4^E11.319
;;^UTILITY(U,$J,358.3,10218,2)
;;=^5002633
;;^UTILITY(U,$J,358.3,10219,0)
;;=E11.3211^^39^431^22
;;^UTILITY(U,$J,358.3,10219,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10219,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
;;^UTILITY(U,$J,358.3,10219,1,4,0)
;;=4^E11.3211
;;^UTILITY(U,$J,358.3,10219,2)
;;=^5138331
;;^UTILITY(U,$J,358.3,10220,0)
;;=E11.3212^^39^431^23
;;^UTILITY(U,$J,358.3,10220,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10220,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
;;^UTILITY(U,$J,358.3,10220,1,4,0)
;;=4^E11.3212
;;^UTILITY(U,$J,358.3,10220,2)
;;=^5138332
;;^UTILITY(U,$J,358.3,10221,0)
;;=E11.3213^^39^431^24
;;^UTILITY(U,$J,358.3,10221,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10221,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
;;^UTILITY(U,$J,358.3,10221,1,4,0)
;;=4^E11.3213
;;^UTILITY(U,$J,358.3,10221,2)
;;=^5138333
;;^UTILITY(U,$J,358.3,10222,0)
;;=E11.40^^39^431^10
;;^UTILITY(U,$J,358.3,10222,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10222,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,10222,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,10222,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,10223,0)
;;=E11.51^^39^431^12
;;^UTILITY(U,$J,358.3,10223,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10223,1,3,0)
;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,10223,1,4,0)
;;=4^E11.51
;;^UTILITY(U,$J,358.3,10223,2)
;;=^5002650
;;^UTILITY(U,$J,358.3,10224,0)
;;=E11.52^^39^431^11
;;^UTILITY(U,$J,358.3,10224,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10224,1,3,0)
;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,10224,1,4,0)
;;=4^E11.52
;;^UTILITY(U,$J,358.3,10224,2)
;;=^5002651
;;^UTILITY(U,$J,358.3,10225,0)
;;=E11.620^^39^431^5
;;^UTILITY(U,$J,358.3,10225,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10225,1,3,0)
;;=3^DM Type 2 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,10225,1,4,0)
;;=4^E11.620
;;^UTILITY(U,$J,358.3,10225,2)
;;=^5002655
;;^UTILITY(U,$J,358.3,10226,0)
;;=E11.36^^39^431^4
;;^UTILITY(U,$J,358.3,10226,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10226,1,3,0)
;;=3^DM Type 2 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,10226,1,4,0)
;;=4^E11.36
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0MQ 3794 printed Sep 23, 2025@19:27:41 Page 2
IBDEI0MQ ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10214,2)
+2 ;;=^5002665
+3 ;;^UTILITY(U,$J,358.3,10215,0)
+4 ;;=E11.9^^39^431^35
+5 ;;^UTILITY(U,$J,358.3,10215,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,10215,1,3,0)
+8 ;;=3^DM Type 2 w/o Complications
+9 ;;^UTILITY(U,$J,358.3,10215,1,4,0)
+10 ;;=4^E11.9
+11 ;;^UTILITY(U,$J,358.3,10215,2)
+12 ;;=^5002666
+13 ;;^UTILITY(U,$J,358.3,10216,0)
+14 ;;=E11.29^^39^431^27
+15 ;;^UTILITY(U,$J,358.3,10216,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,10216,1,3,0)
+18 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
+19 ;;^UTILITY(U,$J,358.3,10216,1,4,0)
+20 ;;=4^E11.29
+21 ;;^UTILITY(U,$J,358.3,10216,2)
+22 ;;=^5002631
+23 ;;^UTILITY(U,$J,358.3,10217,0)
+24 ;;=E11.311^^39^431^14
+25 ;;^UTILITY(U,$J,358.3,10217,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,10217,1,3,0)
+28 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
+29 ;;^UTILITY(U,$J,358.3,10217,1,4,0)
+30 ;;=4^E11.311
+31 ;;^UTILITY(U,$J,358.3,10217,2)
+32 ;;=E11.319^5002632
+33 ;;^UTILITY(U,$J,358.3,10218,0)
+34 ;;=E11.319^^39^431^15
+35 ;;^UTILITY(U,$J,358.3,10218,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,10218,1,3,0)
+38 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
+39 ;;^UTILITY(U,$J,358.3,10218,1,4,0)
+40 ;;=4^E11.319
+41 ;;^UTILITY(U,$J,358.3,10218,2)
+42 ;;=^5002633
+43 ;;^UTILITY(U,$J,358.3,10219,0)
+44 ;;=E11.3211^^39^431^22
+45 ;;^UTILITY(U,$J,358.3,10219,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,10219,1,3,0)
+48 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
+49 ;;^UTILITY(U,$J,358.3,10219,1,4,0)
+50 ;;=4^E11.3211
+51 ;;^UTILITY(U,$J,358.3,10219,2)
+52 ;;=^5138331
+53 ;;^UTILITY(U,$J,358.3,10220,0)
+54 ;;=E11.3212^^39^431^23
+55 ;;^UTILITY(U,$J,358.3,10220,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,10220,1,3,0)
+58 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
+59 ;;^UTILITY(U,$J,358.3,10220,1,4,0)
+60 ;;=4^E11.3212
+61 ;;^UTILITY(U,$J,358.3,10220,2)
+62 ;;=^5138332
+63 ;;^UTILITY(U,$J,358.3,10221,0)
+64 ;;=E11.3213^^39^431^24
+65 ;;^UTILITY(U,$J,358.3,10221,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,10221,1,3,0)
+68 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
+69 ;;^UTILITY(U,$J,358.3,10221,1,4,0)
+70 ;;=4^E11.3213
+71 ;;^UTILITY(U,$J,358.3,10221,2)
+72 ;;=^5138333
+73 ;;^UTILITY(U,$J,358.3,10222,0)
+74 ;;=E11.40^^39^431^10
+75 ;;^UTILITY(U,$J,358.3,10222,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,10222,1,3,0)
+78 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
+79 ;;^UTILITY(U,$J,358.3,10222,1,4,0)
+80 ;;=4^E11.40
+81 ;;^UTILITY(U,$J,358.3,10222,2)
+82 ;;=^5002644
+83 ;;^UTILITY(U,$J,358.3,10223,0)
+84 ;;=E11.51^^39^431^12
+85 ;;^UTILITY(U,$J,358.3,10223,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,10223,1,3,0)
+88 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
+89 ;;^UTILITY(U,$J,358.3,10223,1,4,0)
+90 ;;=4^E11.51
+91 ;;^UTILITY(U,$J,358.3,10223,2)
+92 ;;=^5002650
+93 ;;^UTILITY(U,$J,358.3,10224,0)
+94 ;;=E11.52^^39^431^11
+95 ;;^UTILITY(U,$J,358.3,10224,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,10224,1,3,0)
+98 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
+99 ;;^UTILITY(U,$J,358.3,10224,1,4,0)
+100 ;;=4^E11.52
+101 ;;^UTILITY(U,$J,358.3,10224,2)
+102 ;;=^5002651
+103 ;;^UTILITY(U,$J,358.3,10225,0)
+104 ;;=E11.620^^39^431^5
+105 ;;^UTILITY(U,$J,358.3,10225,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,10225,1,3,0)
+108 ;;=3^DM Type 2 w/ Diab Dermatitis
+109 ;;^UTILITY(U,$J,358.3,10225,1,4,0)
+110 ;;=4^E11.620
+111 ;;^UTILITY(U,$J,358.3,10225,2)
+112 ;;=^5002655
+113 ;;^UTILITY(U,$J,358.3,10226,0)
+114 ;;=E11.36^^39^431^4
+115 ;;^UTILITY(U,$J,358.3,10226,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,10226,1,3,0)
+118 ;;=3^DM Type 2 w/ Diab Cataract
+119 ;;^UTILITY(U,$J,358.3,10226,1,4,0)
+120 ;;=4^E11.36
